TUCSON, AZ - January 14, 2026 - PRESSADVANTAGE - Professor Watson announces significant enhancements to its advertising ...
ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback